Analgesics (Pharmacies) - Honduras

Revenue in the Analgesics market is projected to reach US$26.73m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.60%, resulting in a market volume of US$38.55m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$2.48 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Honduras is experiencing steady growth, driven by customer preferences for over-the-counter pain relief medications and the country's unique local special circumstances.

Customer preferences: Honduran consumers have a growing preference for over-the-counter analgesics, which can be easily obtained from pharmacies without a prescription. This preference is driven by the convenience and accessibility of these medications, as well as the belief that they provide quick relief for common ailments such as headaches, muscle aches, and fever. Additionally, customers in Honduras tend to trust the advice and recommendations provided by pharmacists, further driving the demand for analgesics in pharmacies.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in Honduras is the increasing demand for non-steroidal anti-inflammatory drugs (NSAIDs). These medications, such as ibuprofen and naproxen, are commonly used to relieve pain, reduce inflammation, and lower fever. The growing popularity of NSAIDs can be attributed to their effectiveness in treating a wide range of conditions, from minor aches and pains to more severe inflammatory conditions. Additionally, the affordability and availability of these medications in pharmacies make them a popular choice among consumers. Another trend in the market is the rising demand for natural and herbal analgesics. Many consumers in Honduras are seeking alternative and natural remedies for pain relief, and this has led to an increase in the availability and sales of herbal analgesics in pharmacies. These products often contain ingredients such as turmeric, ginger, or willow bark, which are believed to have anti-inflammatory and pain-relieving properties. The growing interest in natural remedies is driven by a desire for holistic health and wellness solutions.

Local special circumstances: Honduras has a relatively high prevalence of chronic pain conditions, such as arthritis and back pain, which contribute to the demand for analgesics in pharmacies. The country's aging population is also a factor, as older adults are more likely to experience chronic pain and rely on analgesics for relief. Additionally, the lack of universal healthcare coverage in Honduras means that many individuals rely on self-medication and over-the-counter analgesics as a primary form of healthcare.

Underlying macroeconomic factors: The growing Analgesics (Pharmacies) market in Honduras is also influenced by underlying macroeconomic factors. The country's stable economic growth and increasing disposable income levels have contributed to higher consumer spending on healthcare products, including analgesics. Additionally, the expansion of the retail pharmacy sector in Honduras, with more pharmacies opening in urban and rural areas, has increased the accessibility and availability of analgesics for consumers. In conclusion, the Analgesics (Pharmacies) market in Honduras is driven by customer preferences for over-the-counter pain relief medications, including NSAIDs and natural remedies. The local special circumstances, such as the prevalence of chronic pain conditions and the lack of universal healthcare coverage, further contribute to the demand for analgesics in pharmacies. The market is also influenced by underlying macroeconomic factors, such as stable economic growth and the expansion of the retail pharmacy sector.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.